請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48364
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 丁詩同 | |
dc.contributor.author | I-Pin Chou | en |
dc.contributor.author | 鄒逸萍 | zh_TW |
dc.date.accessioned | 2021-06-15T06:54:00Z | - |
dc.date.available | 2016-08-22 | |
dc.date.copyright | 2011-08-22 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011-08-19 | |
dc.identifier.citation | 1. Karbowska, J. and Z. Kochan, Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol, 2006. 57 Suppl 6: p. 103-13.
2. Brochu-Gaudreau, K., et al., Adiponectin action from head to toe. Endocrine, 2010. 37(1): p. 11-32. 3. Nakano, Y., et al., Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem, 1996. 120(4): p. 803-12. 4. You, M. and C.Q. Rogers, Adiponectin: A Key Adipokine in Alcoholic Fatty Liver. Experimental Biology and Medicine, 2009. 234(8): p. 850-859. 5. Pajvani, U.B., et al., Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem, 2003. 278(11): p. 9073-85. 6. Hug, C., et al., T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proceedings of the National Academy of Sciences of the United States of America, 2004. 101(28): p. 10308-10313. 7. Yamauchi, T., et al., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 2001. 7(8): p. 941-6. 8. You, M., et al., Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology, 2005. 42(3): p. 568-77. 9. Yamauchi, T., et al., Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 2003. 423(6941): p. 762-9. 10. Tomas, E., et al., Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A, 2002. 99(25): p. 16309-13. 11. Roepstorff, C., et al., Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol Endocrinol Metab, 2005. 288(1): p. E133-42. 12. Yamauchi, T., et al., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 2002. 8(11): p. 1288-95. 13. Berg, A.H., et al., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med, 2001. 7(8): p. 947-53. 14. Combs, T.P., et al., Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest, 2001. 108(12): p. 1875-81. 15. Onay-Besikci, A., J.Y. Altarejos, and G.D. Lopaschuk, gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts. J Biol Chem, 2004. 279(43): p. 44320-6. 16. Pineiro, R., et al., Adiponectin is synthesized and secreted by human and murine cardiomyocytes. Febs Letters, 2005. 579(23): p. 5163-5169. 17. Tugwood, J.D., et al., The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J, 1992. 11(2): p. 433-9. 18. Ceddia, R.B., et al., Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia, 2005. 48(1): p. 132-9. 19. Kahn, B.B., et al., AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism, 2005. 1(1): p. 15-25. 20. Arita, Y., et al., Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation, 2002. 105(24): p. 2893-8. 21. Arita, Y., et al., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999. 257(1): p. 79-83. 22. Matsubara, M., S. Maruoka, and S. Katayose, Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol, 2002. 147(2): p. 173-80. 23. Cnop, M., et al., Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 2003. 46(4): p. 459-69. 24. Lara-Castro, C., et al., Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes, 2006. 55(1): p. 249-59. 25. Maeda, N., et al., PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001. 50(9): p. 2094-9. 26. Maeda, N., et al., Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med, 2002. 8(7): p. 731-7. 27. Hotta, K., et al., Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol, 2000. 20(6): p. 1595-9. 28. Fruebis, J., et al., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A, 2001. 98(4): p. 2005-10. 29. Kubota, N., et al., Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem, 2002. 277(29): p. 25863-6. 30. Kaser, S., et al., Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut, 2005. 54(1): p. 117-21. 31. Wolf, A.M., et al., Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun, 2004. 323(2): p. 630-5. 32. Wulster-Radcliffe, M.C., et al., Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun, 2004. 316(3): p. 924-9. 33. Neumeier, M., et al., Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol, 2006. 79(4): p. 803-8. 34. Ouchi, N., et al., Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001. 103(8): p. 1057-63. 35. Petridou, E., et al., Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab, 2003. 88(3): p. 993-7. 36. Miyoshi, Y., et al., Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res, 2003. 9(15): p. 5699-704. 37. Otake, S., et al., Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res, 2005. 11(10): p. 3642-6. 38. Wess, J., G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. Faseb Journal, 1997. 11(5): p. 346-54. 39. Yokomizo, T., et al., A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature, 1997. 387(6633): p. 620-4. 40. Scheer, A., et al., Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J, 1996. 15(14): p. 3566-78. 41. Karpichev, I.V., L. Cornivelli, and G.M. Small, Multiple regulatory roles of a novel Saccharomyces cerevisiae protein, encoded by YOL002c, in lipid and phosphate metabolism. J Biol Chem, 2002. 277(22): p. 19609-17. 42. Bullen, J.W., Jr., et al., Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab, 2007. 292(4): p. E1079-86. 43. Fasshauer, M., et al., Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett, 2004. 558(1-3): p. 27-32. 44. Peng, Y., et al., Downregulation of adiponectin/AdipoR2 is associated with steatohepatitis in obese mice. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2009. 13(11): p. 2043-9. 45. Wade, T.E., et al., Adiponectin receptor-1 expression is decreased in the pancreas of obese mice. The Journal of surgical research, 2009. 154(1): p. 78-84. 46. Bauer, S., et al., Low-abundant adiponectin receptors in visceral adipose tissue of humans and rats are further reduced in diabetic animals. Archives of medical research, 2010. 41(2): p. 75-82. 47. Tsuchida, A., et al., Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem, 2004. 279(29): p. 30817-22. 48. Civitarese, A.E., et al., Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia, 2004. 47(5): p. 816-20. 49. Debard, C., et al., Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients. Diabetologia, 2004. 47(5): p. 917-25. 50. Kadowaki, T., Adiponectin and Adiponectin Receptors. Endocrine Reviews, 2005. 26(3): p. 439-451. 51. Bjursell, M., et al., Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes, 2007. 56(3): p. 583-93. 52. Wang, H., et al., Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance. Diabetes, 2004. 53(8): p. 2132-6. 53. Staiger, H., et al., Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes, 2004. 53(9): p. 2195-2201. 54. Kola, B., et al., Expanding role of AMPK in endocrinology. Trends Endocrinol Metab, 2006. 17(5): p. 205-15. 55. Kubota, N., et al., Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab, 2007. 6(1): p. 55-68. 56. Chinetti, G., et al., Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun, 2004. 314(1): p. 151-8. 57. Karbowska, J. and Z. Kochan, Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma. Biochem Pharmacol, 2005. 70(2): p. 249-57. 58. Hug, C., et al., T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A, 2004. 101(28): p. 10308-13. 59. Denzel, M.S., et al., T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest, 2010. 120(12): p. 4342-52. 60. Beare-Rogers, J., A. Dieffenbacher, and J.V. Holm, Lexicon of lipid nutrition. Pure and Applied Chemistry, 2001. 73(4): p. 685-744. 61. Staiger, H., et al., Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes, 2004. 53(12): p. 3209-16. 62. Mead, J.F., Lipid Metabolism. Annu Rev Biochem, 1963. 32: p. 241-68. 63. Basu, J., Protein palmitoylation and dynamic modulation of protein function. Current Science, 2004. 87(2): p. 212-217. 64. O'Byrne, S.M., et al., Multiple pathways ensure retinoid delivery to milk: studies in genetically modified mice. Am J Physiol Endocrinol Metab, 2010. 298(4): p. E862-70. 65. Fu, P.P., et al., Physiological role of retinyl palmitate in the skin. Vitam Horm, 2007. 75: p. 223-56. 66. Unger, R.H., Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes, 1995. 44(8): p. 863-70. 67. Sparagna, G.C., et al., Fatty acid-induced apoptosis in neonatal cardiomyocytes: redox signaling. Antioxid Redox Signal, 2001. 3(1): p. 71-9. 68. Elmore, S., Apoptosis: a review of programmed cell death. Toxicol Pathol, 2007. 35(4): p. 495-516. 69. Kanduc, D., et al., Cell death: apoptosis versus necrosis (review). Int J Oncol, 2002. 21(1): p. 165-70. 70. Ostrander, D.B., et al., Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J Biol Chem, 2001. 276(41): p. 38061-7. 71. Wajant, H., The Fas signaling pathway: more than a paradigm. Science, 2002. 296(5573): p. 1635-6. 72. Hague, A. and C. Paraskeva, Apoptosis and disease: a matter of cell fate. Cell Death and Differentiation, 2004. 11(12): p. 1366-1372. 73. Ji, J., et al., Saturated free fatty acid, palmitic acid, induces apoptosis in fetal hepatocytes in culture. Exp Toxicol Pathol, 2005. 56(6): p. 369-76. 74. Listenberger, L.L., D.S. Ory, and J.E. Schaffer, Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem, 2001. 276(18): p. 14890-5. 75. Cnop, M., et al., Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes, 2001. 50(8): p. 1771-7. 76. Maedler, K., et al., Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes, 2001. 50(1): p. 69-76. 77. Miller, T.A., et al., Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes. Biochem Biophys Res Commun, 2005. 336(1): p. 309-15. 78. Kim, J.E., et al., Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase. Journal of Endocrinology, 2010. 207(1): p. 35-44. 79. Listenberger, L.L., et al., Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A, 2003. 100(6): p. 3077-82. 80. Maedler, K., et al., Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes, 2003. 52(3): p. 726-33. 81. Beeharry, N., J.A. Chambers, and I.C. Green, Fatty acid protection from palmitic acid-induced apoptosis is lost following PI3-kinase inhibition. Apoptosis, 2004. 9(5): p. 599-607. 82. Hardy, S., Y. Langelier, and M. Prentki, Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res, 2000. 60(22): p. 6353-8. 83. Newmeyer, D.D. and S. Ferguson-Miller, Mitochondria: releasing power for life and unleashing the machineries of death. Cell, 2003. 112(4): p. 481-90. 84. Sparagna, G.C., et al., A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol, 2000. 279(5): p. H2124-32. 85. Kong, J.Y. and S.W. Rabkin, Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochim Biophys Acta, 2000. 1485(1): p. 45-55. 86. Kong, J.Y. and S.W. Rabkin, Mitochondrial effects with ceramide-induced cardiac apoptosis are different from those of palmitate. Arch Biochem Biophys, 2003. 412(2): p. 196-206. 87. Dyntar, D., et al., Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes, 2001. 50(9): p. 2105-13. 88. Kong, J.Y. and S.W. Rabkin, Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin. Am J Physiol Heart Circ Physiol, 2002. 282(2): p. H717-25. 89. Piro, S., et al., Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism, 2002. 51(10): p. 1340-7. 90. Finck, B.N., et al., A critical role for PPAR alpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proceedings of the National Academy of Sciences of the United States of America, 2003. 100(3): p. 1226-1231. 91. Hickson-Bick, D.L., et al., Palmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS. Am J Physiol Heart Circ Physiol, 2002. 282(2): p. H656-64. 92. Jung, T.W., et al., Full-length adiponectin protects hepatocytes from palmitate-induced apoptosis via inhibition of c-Jun NH2 terminal kinase. Febs Journal, 2009. 276(8): p. 2278-2284. 93. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983. 65(1-2): p. 55-63. 94. Rozen, S. and H. Skaletsky, Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol, 2000. 132: p. 365-86. 95. Rachek, L.I., et al., Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells. Endocrinology, 2007. 148(1): p. 293-9. 96. Yuzefovych, L., G. Wilson, and L. Rachek, Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress. Am J Physiol Endocrinol Metab, 2010. 299(6): p. E1096-105. 97. Di Paola, M., et al., Ceramide induces release of pro-apoptotic proteins from mitochondria by either a Ca2+ -dependent or a Ca2+ -independent mechanism. J Bioenerg Biomembr, 2004. 36(2): p. 165-70. 98. Yamauchi, T., et al., Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med, 2007. 13(3): p. 332-9. 99. Unger, R.H., Lipotoxic diseases. Annu Rev Med, 2002. 53: p. 319-36. 100. Xiao-Yun, X., et al., Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. Med Sci Monit, 2009. 15(9): p. BR254-61. 101. Wijesekara, N., et al., Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J Biol Chem, 2010. 285(44): p. 33623-31. 102. Ouchi, N., et al., Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem, 2004. 279(2): p. 1304-9. 103. Dhanasekaran, A., et al., Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol, 2008. 294(2): p. H724-35. 104. Han, J.W., et al., Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats. World J Gastroenterol, 2010. 16(48): p. 6111-8. 105. Younossi, Z.M., Nonalcoholic fatty liver disease. Curr Gastroenterol Rep, 1999. 1(1): p. 57-62. 106. Abrass, C.K., et al., Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene. Kidney Int, 2006. 70(6): p. 1062-71. 107. Li, Z.Z., et al., Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem, 2009. 284(9): p. 5637-44. 108. Wei, Y., et al., Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab, 2006. 291(2): p. E275-81. 109. Kamata, H. and H. Hirata, Redox regulation of cellular signalling. Cell Signal, 1999. 11(1): p. 1-14. 110. Trauner, M., M. Arrese, and M. Wagner, Fatty liver and lipotoxicity. Biochim Biophys Acta, 2010. 1801(3): p. 299-310. 111. Okamoto, Y., et al., Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond), 2006. 110(3): p. 267-78. 112. Jung, T.W., et al., Full-length adiponectin protects hepatocytes from palmitate-induced apoptosis via inhibition of c-Jun NH2 terminal kinase. Febs Journal, 2009. 276(8): p. 2278-84. 113. Kadowaki, T. and T. Yamauchi, Adiponectin and adiponectin receptors. Endocr Rev, 2005. 26(3): p. 439-51. 114. Miyazaki, S., et al., Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin. Life Sci, 2010. 86(17-18): p. 691-8. 115. Staiger, H., et al., Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes, 2004. 53(9): p. 2195-201. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48364 | - |
dc.description.abstract | 肝臟中油脂累積過量會引起發炎反應、細胞傷害、肝纖維化甚至肝硬化,亦即非酒精性脂肪肝之症狀。棕櫚酸為血清中含量最多之飽和脂肪酸,且廣泛存在於動植物及及人類日常飲食中,然而其已被證實在多種細胞中會引起細胞毒性,肝細胞亦在其中。
以棕櫚酸(palmitate)處理人類肝臟細胞HepG2,發現細胞內油滴累積上升,ATP產生量下降以及細胞存活率下降,亦即棕櫚酸會造成細胞功能缺損(cell dysfunction),更進一步使細胞死亡。觀察細胞之基因表現,促進脂肪酸進行氧化之基因,包含carnitine palmitoyltransferase I (CPT1),acyl-coA oxidase (ACO),cytochrome c oxidase,peroxisome-proliferator-activated receptor-co-activator 1-alpha(PGC1-alpha),peroxisome-proliferator- activated receptor-alpha(PPAR-alpha),以及促進脂肪酸合成之基因,包含:acetyl-CoA carboxylase (ACC)和fatty acid synthase (FAS)表現均顯著提高,而促進棕櫚酸合成ceramide之基因serine palmitoyltransferase (SPTLC)表現沒有顯著增加,此顯示ceramide可能並非棕櫚酸造成HepG2細胞凋亡之主要原因,另外引起細胞凋亡之caspase 3之基因表現則在棕櫚酸處理後顯著增加。 脂締素受體一(adiponectin receptor 1)為脂締素(adiponectin)之受體,此廣泛地在身體各組織被表現,並且被認為和脂肪酸與糖類代謝有密切之關係;然而其作用機制尚未完全明瞭。此外,目前並沒有此受體和細胞凋亡(apoptosis)之關係之研究。故在本研究中,我們將細胞中脂締素受體一過度表現,以研究脂締素受體一對脂肪代謝及對於細胞凋亡之作用機轉。 在HepG2中過度表現脂締素受體一,再以棕櫚酸處理後,細胞內油滴累積下降,ATP產生量上升,且細胞存活率上升。觀察其基因表現,CPT1,ACO,cytochrome c oxidase,PGC1-alpha和PPAR-alpha表現量均顯著上升,推測可能導致脂肪酸氧化增加,進而使能量產生增加。而ACC和FAS基因表現則顯著下降,和細胞油滴減少之結果一致。此外,caspase 3表現下降,均可能是脂締素受體一保護細胞免於死亡之機轉。 同時,我們觀察到在過度表現脂締素受體一的細胞中,磷酸化之AKT含量增加,且抑制其磷酸化後,脂締素受體一的保護作用消失,也就是ATP產生量再度下降,細胞存活率再度降低。綜合以上所述,脂締素受體一對於細胞在棕櫚酸處理之下具有保護效果,其效果部分來自於促進磷酸化AKT增加,除此之外,於基因之調控也為其作用之一。此研究成果對於肝臟之細胞功能缺失及死亡有進一步的了解,亦即在非酒精性脂肪肝中,脂締素受體一為一有潛力之治療標的。 | zh_TW |
dc.description.abstract | Hepatic lipid overloading mainly in the form of triglyceride accumulation, which can result in the inflammatory response, cause hepatocyte damage, fibrosis, and eventually progress to cirrhosis, is associated with nonalcoholic fatty liver disease. The most abundant saturated fatty acid in plasma is palmitate, which is also common in a wide range of plant and animal sources. However, it is found lipotoxic in a variety of cell types, including hepatocytes.
Exposure of human hepatocytes HepG2 to 0.2 mM or 0.4 mM palmitate for 24 hours resulted in raising lipid accumulation and decreasing ATP production and cell viability, suggesting the lipotoxicity of palmitate. Expression of genes related to fatty acid metabolism and cell apoptosis was affected by palmitate treatment. Expression of rate-limiting regulator in fatty acid oxidation carnitine palmitoyltransferase I (CPT1) was elevated in transcription level, and other genes, such as acyl-coA oxidase (ACO), cytochrome c oxidase, peroxisome-proliferator-activated receptor-co-activator 1-alpha(PGC1-alpha), peroxisome-proliferator- activated receptor-alpha(PPAR-alpha) and acetyl-CoA carboxylase (ACC) were increased slightly, while fatty acid synthase (FAS) was increased significantly. On the other hand, the mRNA expression of caspase 3 was increased significantly. In brief, palmitate contributed to cell dysfunction, and led to cell death ultimately. Adiponectin and its receptors play important roles in regulating lipid metabolism. In the second experiment, we over-expressed adiponectin receptor 1 in HepG2 cells by lentivirus system to define its role in the development of fatty liver syndrome. First of all, mRNA level of adiponectin receptor 1 in adiponectin receptor 1 transfected-HepG2 (AdipoR1) cells was 1.5-fold higher than the mock vector transfected-HepG2 cells (mock). Meanwhile, the protein expression of FLAG, which was constructed at the adiponectin receptor 1 vector, was 5-fold higher than the mock. When AdipoR1 cells were cultured with palmitate, fatty acid transport protein 2 (FATP2), ACO, CPT1, cytochrome c oxidase, and PPAR-alpha were significantly increased, but FAS, ACC, and PGC1-alpha were significantly decreased compared to mock group. In addition, ATP production was increased whereas the lipid accumulation was reduced in AdipoR1 transfected-HepG2 cells. These results suggest that adiponectin receptor 1 improves fatty acid metabolism, by increasing fatty acid up take and oxidation. We then investigated the cell death of palmitate-treated AdipoR1 cells. At 20 hours, cell viability of AdipoR1 cells was significantly higher than that of mock group, furthermore, annexin V positive cells of which was much lower. Additionally, the gene expression of caspase 3 was decreased significantly in AdipoR1 cells. Namely, adiponectin receptor 1 ameliorates palmitate-induced apoptosis in HepG2 cells. Meanwhile the phosphorylation of AKT was increased in AdipoR1 cells, and when PI3 kinase inhibitor was applied, the protective effect of adiponectin receptor 1 was absent, with which ATP production was decreased again and so did the cell viability by palmitate. Taken together, adiponectin receptor 1 enhances fatty acid metabolism and cell viability when treated with palmitate partially by activating AKT signaling. Therefore adiponectin receptor 1 serves a potential therapeutic target in nonalcoholic fatty liver disease. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T06:54:00Z (GMT). No. of bitstreams: 1 ntu-100-R98626015-1.pdf: 1114258 bytes, checksum: 95eceacc2dd054aa63ec7e1f8fa9ff4c (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 誌謝 i
中文摘要 ii ABSTRACT iv CONTENTS vi LIST OF FIGURES vii LIST OF TABLES ix Chapter 1 Literature Review 1 Chapter 2 Materials and Methods 13 2.1 Materials 13 2.2 Cell culture & palmitate treatment 13 2.3 Transfection 13 2.4 MTT assay 14 2.5 Flow cytometry 15 2.6 Inhibition of PI3-kinase pathways 15 2.7 Oil red O staining 16 2.8 Real-time PCR 16 2.9 Protien expression and Western blotting 17 2.10 Data analysis 17 Chapter 3 Results 18 Figures 23 Chapter 4 Discussion 41 Chapter 5 Reference 45 | |
dc.language.iso | en | |
dc.title | 脂締素受體一藉由PI3K/AKT路徑促進肝細胞脂肪酸代謝及細胞存活率 | zh_TW |
dc.title | Adiponectin receptor 1 enhances fatty acid metabolism and cell viability in HepG2 cells through PI3K/AKT pathway | en |
dc.type | Thesis | |
dc.date.schoolyear | 99-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 陳靜宜 | |
dc.contributor.oralexamcommittee | 李宣書,陳洵一 | |
dc.subject.keyword | 脂締素受體,肝臟,細胞凋亡,細胞毒性, | zh_TW |
dc.subject.keyword | adiponectin receptor,HepG2,apoptosis,cytotoxicity, | en |
dc.relation.page | 51 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2011-08-20 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 1.09 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。